Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LNX1 antisense RNA 2 (LNX1-AS2)
- Target
- LNX1-AS2
- Molecular classification
- Other (long non-coding RNA; lncRNA)
01
Overview
LNX1 antisense RNA 2 (LNX1-AS2) is a long non-coding RNA transcribed from the antisense strand of the LNX1 locus. It does not encode a protein. Elevated LNX1-AS2 expression is associated with poorer overall and disease-specific survival in patients with lung adenocarcinoma, independent of gender or race. High LNX1-AS2 expression is also correlated with increased immune infiltration in tumors and may impact metabolic and immune pathways. Its function appears to be regulatory—modulating gene expression and possibly affecting cellular responses to therapy. There is currently no evidence that LNX1-AS2 acts as a receptor, enzyme, or direct drug target. Rather, its value lies in its potential as a diagnostic or prognostic biomarker in oncology, especially for lung adenocarcinoma[2][3].
- Other names
- LNX1-AS2LNX1 antisense RNA 2 (non-protein coding)
02
Biological functions
Regulation of gene expression (especially associated with immune infiltration and cancer prognosis)possible involvement in epigenetic or transcriptional control
03
Disease associations
Cancer (notably lung adenocarcinoma)possible roles suggested but not well-established in other cancers or diseases
04
Biomarkers
LNX1-AS2 expression may serve as a prognostic biomarker for lung adenocarcinoma and a predictor of immunotherapy response
Beyond the preview
Go deeper on LNX1 antisense RNA 2 (LNX1-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LNX1 antisense RNA 2 (LNX1-AS2).